Tyers Asset Management LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 189 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tyers Asset Management LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$94,000
-12.1%
1,2960.0%0.00%
-25.0%
Q2 2019$107,000
+17.6%
1,2960.0%0.00%
+33.3%
Q1 2019$91,000
+56.9%
1,2960.0%0.00%
+50.0%
Q4 2018$58,000
-20.5%
1,2960.0%0.00%0.0%
Q3 2018$73,000
+7.4%
1,296
+26.6%
0.00%0.0%
Q2 2018$68,000
+13.3%
1,0240.0%0.00%0.0%
Q1 2018$60,000
-9.1%
1,0240.0%0.00%0.0%
Q4 2017$66,000
+43.5%
1,024
+16.4%
0.00%0.0%
Q3 2017$46,000
+35.3%
880
+19.6%
0.00%
+100.0%
Q2 2017$34,000
+112.5%
736
+130.0%
0.00%0.0%
Q1 2017$16,0003200.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders